ChemicalBook--->CAS DataBase List--->1246819-84-0

1246819-84-0

1246819-84-0 Structure

1246819-84-0 Structure
IdentificationBack Directory
[Name]

PIQCTGMSNWUMAF-UFBJYANTSA-N
[CAS]

1246819-84-0
[Synonyms]

PIQCTGMSNWUMAF-UFBJYANTSA-N
[Molecular Formula]

C21H13D8FN6O
[MDL Number]

MFCD34567939
[MOL File]

1246819-84-0.mol
[Molecular Weight]

400.479
Chemical PropertiesBack Directory
[storage temp. ]

Store at -20°C
[solubility ]

Acetonitrile:Methanol (1:1): soluble; DMSO: soluble
[form ]

A solid
Hazard InformationBack Directory
[Description]

Dovitinib-d8 is intended for use as an internal standard for the quantification of dovitinib (Item No. 15220) by GC- or LC-MS. Dovitinib is a multi-kinase inhibitor. It inhibits the receptor tyrosine kinases FLT3, CSF1R, and c-Kit (IC50s = 1, 36, and 2 nM, respectively), as well as FGFR1, FGFR3, VEGFR1-3, PDFGRα, and PDGFRβ (IC50s = 8, 9, 10, 13, 8, 27, and 210 nM, respectively). Dovitinib inhibits proliferation of human multiple myeloma cell lines expressing mutant, but not wild-type, FGFR3 (IC50s = 90-550 and >2,500 nM, respectively). It decreases FGF-induced ERK1/2 phosphorylation and induces apoptosis in patient-derived multiple myeloma cells when used at a concentration of 500 nM. Dovitinib (3-300 mg/kg for eight days) inhibits bFGF-induced angiogenesis in a Matrigel™ plug assay in mice. It reduces tumor growth in KM12L4A colon, DU145 prostate, and MV4-11 acute myelogenous leukemia mouse xenograft models with ED50 values of 17, 23, and 3 mg/kg per day, respectively.
[Uses]

Compound used in treating melanoma
[storage]

Store at -20°C
[References]

[1] SUZANNE TRUDEL. CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma.[J]. Blood, 2005: 2941-2948. DOI: 10.1182/blood-2004-10-3913
[2] PAUL A. RENHOWE*. Design, Structure?Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors[J]. Journal of Medicinal Chemistry, 2008, 52 2: 278-292. DOI: 10.1021/jm800790t
1246819-84-0 suppliers list
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774 400-920-5774
Website: www.glpbio.cn
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Website: http://www.chemegen.com
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: CHINA ISOTOPE CO., LIMITED  
Tel: 02151600108 13062666369
Website: www.isotopechem.com/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd  
Tel: 18162595016; 18162595016
Website: https://www.chemicalbook.com/supplier/25457231/
Company Name: Cayman Chemical Company  
Tel: 800-364-9897
Website: www.caymanchem.com
Company Name: Biosynth Biological Technology (Suzhou) Co Ltd  
Tel: 51288865780
Website: www.biosynth.com
Company Name: Cayman Chemical Company  
Tel: (800) 364-9897
Website: www.caymanchem.com
Company Name: Pharma Affiliates  
Tel: 172-5066494
Website: www.chemicalbook.com/ShowSupplierProductsList694812/0_EN.htm
Company Name: Pharmaffiliates Analytics and Synthetics P. Ltd  
Tel: +91-172-5066494
Website: www.pharmaffiliates.com
Tags:1246819-84-0 Related Product Information
405169-16-6 1174683-49-8 1562993-37-6 852433-84-2 2468771-43-7